Renée Randazzo
About Renée Randazzo
Renée Randazzo is the Director of Oncology Biologics Development at Bristol-Myers Squibb in Hopewell, New Jersey, with over 20 years of experience in various roles within the company.
Title
Renée Randazzo is currently the Director of Oncology Biologics Development at Bristol-Myers Squibb. Based in Hopewell, New Jersey, United States, she has taken on this role since December 2016, bringing a wealth of experience to her leadership in the development of biologics for oncology.
Current Role at Bristol-Myers Squibb
As the Director of Oncology Biologics Development at Bristol-Myers Squibb, Renée Randazzo leads the development of biologic treatments within the oncology sector. Her role involves overseeing the strategic planning and execution of project initiatives to advance biologic therapies, positioning her at the forefront of innovation within the company.
Career at Bristol-Myers Squibb
Renée Randazzo has accumulated over 20 years of experience at Bristol-Myers Squibb. Her career trajectory within the company demonstrates a steady progression through various impactful roles. She has served as an Integrated Development Team Leader from 2014 to 2016, and as a CMC Manager specializing in project planning and management from 2012 to 2014. Between 1999 to 2012, she worked as a Chemical Process Development Engineer, where she honed her technical expertise. Over the years, she has transitioned into more senior roles, reflecting her expanding skill set and leadership capabilities.
Education and Expertise
Renée Randazzo studied at the University of Pennsylvania, where she gained foundational knowledge that has been integral to her career in the pharmaceutical industry. Her educational background, combined with extensive practical experience, has equipped her with expertise in chemical process development, project planning, and managerial skills. This diverse skill set supports her current role in directing oncology biologics development at Bristol-Myers Squibb.